Long-Acting Reversible Contraception

Key Points

• LARC methods (IUD/IUC and implant) are among the most effective reversible contraception options and are not adherence-dependent day to day.
• Typical effectiveness is very high (about 99 percent): etonogestrel implant (~3 years), hormonal IUDs (~3-8 years by product), and copper IUD (about 10 years in common counseling frameworks).
• LARCs are office-based procedures with rapid return to fertility after removal.
• LARCs do not protect against STIs, so dual-protection counseling remains necessary.
• Key safety education includes recognition of pregnancy, expulsion/misplacement, perforation, and infection warning signs.

Pathophysiology

LARC methods prevent pregnancy through sustained local or systemic progestin effects (depending on device) or nonhormonal intrauterine copper effects that disrupt sperm function and fertilization capacity. Because contraceptive action is continuous after placement, method efficacy is less influenced by daily user adherence compared with short-acting methods.

Hormonal intrauterine devices may reduce endometrial proliferation and menstrual volume, and in some patients lead to amenorrhea. Copper intrauterine devices provide a hormone-free long-duration option with broad candidacy when contraindications are absent. Subdermal implants provide prolonged progestin-mediated suppression effects and high reliability. LARC placement is office-based with minimal downtime, and fertility generally returns rapidly after removal. LNG-IUC amenorrhea rates vary by product dose (commonly about 6 to 20 percent), and product duration differs (for example approximately 3 to 8 years by type). Copper T380A pathways are commonly counseled for about 10 years with very high efficacy, but heavier bleeding/cramping can occur after insertion, often improving over subsequent weeks. Copper IUC pathways are commonly selected when a patient wants nonhormonal contraception (for example breastfeeding contexts, hormone-avoidance preferences, or estrogen-risk profiles).

Although uncommon, complications can be serious and require early recognition: ectopic pregnancy risk when method failure occurs, device expulsion or misplacement, uterine perforation during/after placement, and infection-related sequelae. Nursing follow-up and symptom teaching are central to safe long-term use.

Classification

• Hormonal intrauterine devices: Levonorgestrel-releasing devices with multi-year duration.
• Nonhormonal intrauterine device: Copper IUD option with long duration and no estrogen/progestin exposure.
• Subdermal implant: Progestin-containing upper-arm implant for extended contraception.
• Complication domains: Pregnancy failure, expulsion/malposition, perforation, and infection/PID-related risk.
• Complication domains: Pregnancy failure, expulsion/malposition, perforation, and infection/PID-related risk (highest PID risk window is first 3 weeks after insertion).
• Method-specific candidacy concerns: Etonogestrel implant (pregnancy, active liver disease, unexplained bleeding, breast cancer history, thrombotic history); copper IUD (copper allergy, Wilson disease, heavy-bleeding risk contexts such as SLE).

Nursing Assessment

NCLEX Focus

Prioritize candidacy assessment, informed consent, and post-placement complication surveillance education.

• Assess pregnancy status and contraindications before placement.
• Evaluate need for nonhormonal versus hormonal contraception based on risk profile and preferences.
• Assess readiness for long-duration contraception and understanding of STI nonprotection.
• Establish baseline bleeding pattern and expectations for post-placement bleeding changes.
• Screen ability to perform monthly placement checks (strings for IUD/IUC, palpation for implant).
• Screen ability to perform monthly placement checks (strings for IUD/IUC, palpation for implant) and respond quickly if checks are abnormal.
• Confirm plan for early follow-up after placement (commonly about 4-6 weeks for IUD placement check).

Nursing Interventions

• Provide balanced counseling on efficacy, duration, reversibility, and expected side effects.
• Clarify menstrual trade-offs during method selection: LNG-IUD often improves heavy bleeding/dysmenorrhea over time, copper IUD may increase early bleeding/cramping, and etonogestrel implant commonly causes unpredictable spotting.
• Clarify menstrual trade-offs during method selection: LNG-IUD often improves heavy bleeding/dysmenorrhea over time, copper IUD may increase early bleeding/cramping (often in first 2 to 6 weeks), and etonogestrel implant commonly causes unpredictable spotting.
• Teach self-check routines and backup-contraception use if placement is uncertain.
• Teach self-check routines and backup-contraception use if placement is uncertain; postpartum insertions need extra vigilance because expulsion risk is higher.
• Educate on urgent warning symptoms using PAINS framing after IUC placement: P period late/missing or new spotting after prior stability, A sharp/severe abdominal pain, I infection symptoms (discharge/odor), N not feeling well (fever/chills/malaise), S strings not felt.
• Reinforce immediate reporting of suspected pregnancy, severe pain, heavy bleeding, fever, or missing strings/implant.
• Give explicit urgent-bleeding thresholds after insertion (for example soaking more than about one pad per hour) and reinforce immediate contact if reached.
• For implant users, teach urgent reassessment if the rod is no longer palpable because rare migration can lead to serious complications.
• If PID develops with an IUC in place, explain that treatment can begin with device in place and removal is typically considered if no improvement occurs within 48 to 72 hours.
• Support informed, person-centered choice including adolescent and high-risk populations that may benefit from adherence-independent methods.
• Include proactive counseling for high-risk unintended-pregnancy groups (for example adolescents and limited-access populations) where adherence-independent contraception may improve outcomes.

Hidden-Complication Delay

Delayed response to missing strings, severe pain, or pregnancy symptoms with LARC in place can allow ectopic pregnancy or perforation complications to progress.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
levonorgestrel-intrauterine-system	Mirena, Liletta, Kyleena, Skyla contexts	May reduce heavy bleeding/cramping; counsel on irregular bleeding and device-check routines.
Long Acting Reversible Contraception (etonogestrel-implant)	Nexplanon context	High efficacy with prolonged duration; teach monthly palpation and insertion-site symptom monitoring.

Clinical Judgment Application

Clinical Scenario

A patient with a hormonal IUD reports new severe unilateral pelvic pain, light bleeding after prior amenorrhea, and inability to feel strings.

• Recognize Cues: Possible malposition, expulsion, or pregnancy complication with device in place.
• Analyze Cues: Symptoms raise concern for ectopic pregnancy or perforation-related complication.
• Prioritize Hypotheses: Immediate priority is emergent evaluation rather than routine follow-up.
• Generate Solutions: Advise urgent assessment, pregnancy testing, and imaging/device-location confirmation.
• Take Action: Escalate promptly and advise backup contraception until status is clarified.
• Evaluate Outcomes: Complication is identified early, managed safely, and contraceptive plan is updated.

Related Concepts

• short-acting-reversible-hormonal-methods-of-contraception - LARC is an alternative when short-acting adherence is difficult.
• contraception-the-nurses-role - Counseling and informed consent are foundational to safe LARC selection.
• barrier-methods-of-contraception - Condom use remains important for STI prevention while using LARC.
• emergency-contraception - Relevant if expulsion/method failure occurs before replacement.
• health-promotion-across-the-reproductive-lifespan - LARC suitability varies by reproductive goals and stage.

Self-Check

1. Why are LARCs more effective in typical use than daily or weekly user-dependent methods?
2. Which post-placement findings require immediate emergency evaluation?
3. How should STI-prevention counseling be integrated for patients choosing LARC?